Announcements Trials
Browse Landscape

Status

Completed 15Unknown 3Terminated 3No longer available 2Active not recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Expanded_access 2

Sponsor

Cancer Type

Thoracic 2Plasma cell 1Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Lymphoma, Large-Cell, Anaplastic 1Granuloma, Plasma Cell 1

Interventions

ceritinib 2tazemetostat 1taletrectinib 1sotorasib 1rovalpituzumab tesirine 1rociletinib 1pegilodecakin 1patritumab deruxtecan 1osimertinib 1lorlatinib 1dabrafenib 1capmatinib 1brigatinib 1belagenpumatucel L 1alectinib 1Suspensions 1Powders 1Paclitaxel 1Nivolumab 1Crizotinib 1BID protein, human 1AM0010 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
No longer available × ceritinib × Thoracic × Clear all
NCT05100134 2026-04-01

Managed Access Programs for LDK378, Ceritinib

Novartis

No longer available
LymphoidPlasma cellThoracic

Carcinoma, Non-Small-Cell Lung, Granuloma, Plasma Cell, Lymphoma, Large-Cell, Anaplastic

NCT01947608 2020-11-03

Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC

Novartis

No longer available
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡